FDA.reportPublic FDA data

ferrous bisglycinate 36.5 MG Oral Tablet

RxCUI
2672922
RxNorm name
ferrous bisglycinate 36.5 MG Oral Tablet
Display name
ferrous bisglycinate 36.5 MG Oral Tablet
Full name
ferrous bisglycinate 36.5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
levonorgestrel and ethinyl estradiolLEVONORGESTREL AND ETHINYL ESTRADIOLAcella Pharmaceuticals167b12a0-cdff-4081-a0a4-164482c239fa2025-12-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2672922
BalcoltraLEVONORGESTREL AND ETHINYL ESTRADIOLAvion Pharmaceuticals752ab698-4b48-4614-8016-d1d33ee7c0072025-12-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2672922
AVERIDESOGESTREL AND ETHINYL ESTRADIOLAvion Pharmaceuticals, LLC91359e20-0de1-4995-b525-58b7544e34dc2025-06-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2672922
MINZOYALEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS BISGLYCINATELupin Pharmaceuticals, Inc.d5ebd7fa-c388-4619-8dcb-e862e4ce52852025-01-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2672922

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
752ab698-4b48-4614-8016-d1d33ee7c007ferrous bisglycinate 36.5 MG Oral Tablet [PSN] · ferrous bisglycinate 36.5 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use BALCOLTRA ® safely and effectively. See Full Prescribing Information for BALCOLTRA ® . BALCOLTRA ® (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) for oral administration Initial U.S. Approval: 199720251205
167b12a0-cdff-4081-a0a4-164482c239faferrous bisglycinate 36.5 MG Oral Tablet [PSN] · ferrous bisglycinate 36.5 MG Oral Tablet [SCD]25These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS AND FERROUS BISGLYCINATE TABLETS safely and effectively. See Full Prescribing Information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS AND FERROUS BISGLYCINATE TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets and FERROUS BISGLYCINATE tablets for oral administration Initial U.S. Approval: 199720251205
91359e20-0de1-4995-b525-58b7544e34dcferrous bisglycinate 36.5 MG Oral Tablet [PSN] · ferrous bisglycinate 36.5 MG Oral Tablet [SCD]22AVERI™ Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg and Ferrous Bisglycinate Tablets, 36.5 mg20250605
d5ebd7fa-c388-4619-8dcb-e862e4ce5285ferrous bisglycinate 36.5 MG Oral Tablet [PSN] · ferrous bisglycinate 36.5 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use MINZOYA safely and effectively. See full prescribing information for MINZOYA. MINZOYA (levonorgestrel and ethinyl estradiol tablets, and ferrous bisglycinate tablets), for oral use. Initial U.S. Approval: 1998.20250109